Overcoming Ceftaroline Resistance in MRSA Using Ceftaroline–Carbapenem Combination Therapy - Poll - MDSpire

Overcoming Ceftaroline Resistance in MRSA Using Ceftaroline–Carbapenem Combination Therapy

  • By

  • Joshua Olson

  • Valliammai Alaguvel

  • Gabriel Pérez-Parra

  • Allen Jankeel

  • Anuj K Khetarpal

  • Valeria Rodríguez-Guevara

  • Vanessa Vu

  • George Sakoulas

  • Erlinda R Ulloa

  • January 20, 2026

  • 0 min

Share

Original Source(s)

Overcoming Ceftaroline Resistance in MRSA Using Ceftaroline–Carbapenem Combination Therapy

  • by Joshua Olson, Valliammai Alaguvel, Gabriel Pérez-Parra, Allen Jankeel, Anuj K Khetarpal, Valeria Rodríguez-Guevara, Vanessa Vu, George Sakoulas, Erlinda R Ulloa

  • January 20, 2026

Related Content

The toxic effects of α-hemolysin and β-hemolysin produced by Staphylococcus aureus

Evaluating the Role of Treatment Accessibility in HIV-TB Co-Infection: A Comparative Approach Using Fractional-Order Modeling

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.